Kiora Pharmaceuticals logo

Kiora Pharmaceuticals Share Price (NASDAQ: KPRX)

$2.68

0.06

(2.29%)

Last updated on

Check the interactive Kiora Pharmaceuticals Stock chart to analyse performance

Kiora Pharmaceuticals stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$2.55
    Today's High:$2.68

    Day's Volatility :4.85%

  • 52 Weeks Low:$2.25
    52 Weeks High:$4.18

    52 Weeks Volatility :46.17%

Kiora Pharmaceuticals Stock Returns

PeriodKiora Pharmaceuticals IncIndex (Russel 2000)
3 Months
-13.85%
0.0%
6 Months
-23.88%
0.0%
1 Year
-32.36%
0.0%
3 Years
-94.64%
-7.8%

Kiora Pharmaceuticals Inc Key Stats

Check Kiora Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.62
Open
$2.56
Today's High
$2.68
Today's Low
$2.55
Market Capitalization
$9.1M
Today's Volume
$27.1K
52 Week High
$4.18
52 Week Low
$2.25
Revenue TTM
$0.0
EBITDA
$-9.5M
Earnings Per Share (EPS)
$-3.36
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-43.39%

Stock Returns calculator for Kiora Pharmaceuticals Stock including INR - Dollar returns

The Kiora Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kiora Pharmaceuticals investment value today

Current value as on today

₹75,403

Returns

₹24,597

(-24.6%)

Returns from Kiora Pharmaceuticals Stock

₹28,912 (-28.91%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Kiora Pharmaceuticals Stock

-19%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Search interest for Kiora Pharmaceuticals Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Kiora Pharmaceuticals Inc

  • Name

    Holdings %

  • Rosalind Advisors, Inc.

    8.22%

  • AIGH Capital Management, LLC

    7.11%

  • Nantahala Capital Management, LLC

    6.94%

  • Stonepine Capital Management Llc

    6.59%

  • ADAR1 Capital Management LLC

    6.40%

  • Velan Capital Investment Management LP

    4.02%

Analyst Recommendation on Kiora Pharmaceuticals Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Kiora Pharmaceuticals(by analysts ranked 0 to 5 stars)

Kiora Pharmaceuticals Share Price Target

What analysts predicted

Upside of 310.45%

Target:

$11.00

Current:

$2.68

Kiora Pharmaceuticals share price target is $11.00, a slight Upside of 310.45% compared to current price of $2.68 as per analysts' prediction.

Kiora Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, KPRX stock has moved down by -13.0%
  • KPRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 99.0%
  • KPRX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 109.5% return, outperforming this stock by 204.3%

Kiora Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Kiora Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Kiora Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kiora Pharmaceuticals Inc logo
-16.39%
-23.88%
-32.36%
-94.64%
-99.61%
Regeneron Pharmaceuticals, Inc. logo
4.38%
-17.37%
-50.85%
-2.23%
-0.91%
Beone Medicines Ltd logo
5.81%
21.35%
61.84%
78.01%
32.14%
Vertex Pharmaceuticals Incorporated logo
-16.34%
-17.97%
-17.9%
35.76%
47.74%
Alnylam Pharmaceuticals, Inc. logo
38.5%
82.49%
66.63%
105.56%
244.81%

About Kiora Pharmaceuticals Inc

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Organization
Kiora Pharmaceuticals
Employees
12
CEO
Dr. Eric J. Daniels M.B.A., M.D.
Industry
Miscellaneous

Key Management of Kiora Pharmaceuticals Inc

NameTitle
Dr. Eric J. Daniels M.B.A., M.D.
Chief Development Officer
Dr. Stefan Sperl Ph.D.
Executive Vice President of CMC & Operations

Important FAQs about investing in KPRX Stock from India :

What is Kiora Pharmaceuticals share price today?

Kiora Pharmaceuticals share price today is $2.68 as on at the close of the market. Kiora Pharmaceuticals share today touched a day high of $2.68 and a low of $2.55.

What is the 52 week high and 52 week low for Kiora Pharmaceuticals share?

Kiora Pharmaceuticals share touched a 52 week high of $4.18 and a 52 week low of $2.25. Kiora Pharmaceuticals stock price today i.e. is closed at $2.68, lower by 35.89% versus the 52 week high.

How to invest in Kiora Pharmaceuticals Stock (KPRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kiora Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiora Pharmaceuticals Shares that will get you 0.5597 shares as per Kiora Pharmaceuticals share price of $2.68 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Kiora Pharmaceuticals Stock (KPRX) from India?

Indian investors can start investing in Kiora Pharmaceuticals (KPRX) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Kiora Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Kiora Pharmaceuticals share’s latest price of $2.68 as on August 23, 2025 at 1:29 AM IST, you will get 3.7313 shares of Kiora Pharmaceuticals. Learn more about fractional shares .

What are the returns that Kiora Pharmaceuticals has given to Indian investors in the last 5 years?

Kiora Pharmaceuticals stock has given -99.61% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?